A targeted proteomics-based pipeline for verification of biomarkers in plasma
about
Bulked sample analysis in genetics, genomics and crop improvementExpanding the Repertoire of Biomarkers for Alzheimer's Disease: Targeted and Non-targeted ApproachesApplications of targeted proteomics in systems biology and translational medicineMass spectrometry for translational proteomics: progress and clinical implicationsBiomarkers in Alzheimer's disease analysis by mass spectrometry-based proteomicsCerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation.Current application of proteomics in biomarker discovery for inflammatory bowel diseaseSystems Proteomics View of the Endogenous Human Claudin Protein FamilyDifferential diagnosis of azoospermia with proteomic biomarkers ECM1 and TEX101 quantified in seminal plasmaIdentification of direct target engagement biomarkers for kinase-targeted therapeuticsDetermination of variation parameters as a crucial step in designing TMT-based clinical proteomics experimentsIntegrative analysis to select cancer candidate biomarkers to targeted validation.Recent advances in mass spectrometry: data independent analysis and hyper reaction monitoring.The use of biophysical proteomic techniques in advancing our understanding of diseases.Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studiesCirculating proteolytic signatures of chemotherapy-induced cell death in humans discovered by N-terminal labeling.Discovery of colorectal cancer biomarker candidates by membrane proteomic analysis and subsequent verification using selected reaction monitoring (SRM) and tissue microarray (TMA) analysisA blood-based proteomic classifier for the molecular characterization of pulmonary nodules.Detection of Mycobacterium tuberculosis peptides in the exosomes of patients with active and latent M. tuberculosis infection using MRM-MSPeptideManager: a peptide selection tool for targeted proteomic studies involving mixed samples from different species.Expediting SRM assay development for large-scale targeted proteomics experiments.Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics.Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics.Ensembles of protein termini and specific proteolytic signatures as candidate biomarkers of disease.Toward rapid, high-sensitivity, volume-constrained biomarker quantification and validation using backscattering interferometryPreclinical evaluation of a TEX101 protein ELISA test for the differential diagnosis of male infertilityMapping O-glycosylation of apolipoprotein C-III in MALDI-FT-ICR protein profiles.N-glycoprotein SRMAtlas: a resource of mass spectrometric assays for N-glycosites enabling consistent and multiplexed protein quantification for clinical applications.Analytical validation considerations of multiplex mass-spectrometry-based proteomic platforms for measuring protein biomarkers.Computational biomarker pipeline from discovery to clinical implementation: plasma proteomic biomarkers for cardiac transplantation.Using an isolated rat kidney model to identify kidney origin proteins in urine.Anti-peptide monoclonal antibodies generated for immuno-multiple reaction monitoring-mass spectrometry assays have a high probability of supporting Western blot and ELISA.Affinity proteomics reveals elevated muscle proteins in plasma of children with cerebral malariaAutomated sample preparation platform for mass spectrometry-based plasma proteomics and biomarker discoveryPeptide immunoaffinity enrichment coupled with mass spectrometry for peptide and protein quantification.Serial analysis of 38 proteins during the progression of human breast tumor in mice using an antibody colocalization microarray.Proteomics in cancer biomarkers discovery: challenges and applications.Monitoring host responses to the gut microbiotaDistinct serum proteome profiles associated with collagen-induced arthritis and complete Freund's adjuvant-induced inflammation in CD38⁻/⁻ mice: The discriminative power of protein species or proteoforms.4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer.
P2860
Q26753827-6916B586-CEEC-4EEB-ABBD-D05B31ADEB91Q26770708-F78244E3-2FE1-4690-9B1E-E6A6BD54C63EQ26852271-6F1579A3-832F-4A26-B578-DCFDEB9A8EC9Q26995497-6CA04491-BB31-45B7-9F37-11F55588F430Q27024518-1A938A30-38CF-4C5B-855D-5E307EA4A62DQ27311994-C7E8DC3D-B5BD-4B24-8152-62F3E5E8458AQ28078755-65D9837A-AB70-4FFA-A811-F17155E1C852Q28271194-22300046-02F7-4247-AB39-3E00C5CD6E13Q28302387-128A85E9-CBB8-49F2-A416-6026CB86FB2EQ28477593-5F7479FE-51DF-40E5-9667-6DC2174D6203Q28544078-BBEFB0D2-72DA-4CEE-8787-4C7F1209CA5CQ30278389-833C7420-CAE8-4535-AE82-320B5A8A1BB7Q30691039-BF5BCBD3-C8C0-4412-A1BB-04F96CFD0421Q33639590-668F372A-0721-4D2E-8CBD-75E36F89EC86Q33688759-9481940C-24C0-45D1-AC11-C88F9023D56EQ33694691-078A806D-2F1F-4255-976E-E3F614F5AA7BQ33718710-C3FADBB9-64A7-4704-9888-D0D50FC797CBQ33968948-C2C1065C-8469-4EE0-BCC3-708B11DDBE41Q33982504-C55EC238-CBCC-429D-AA88-55CFE65EE04FQ34117442-D65C1332-0FDE-4B4A-9128-739EBB7C975DQ34286018-32AECE41-E305-401A-85D3-3DAA6BAC15CCQ34292436-104AE031-CC6E-4102-AF18-641B20473D3AQ34333925-2495D97A-8C8C-4133-88E9-FCC68560921CQ34402330-2D1628F6-0781-4823-B3AA-89AD485CAA02Q34434036-5427462D-FAA6-48E7-BEFA-D68285F12214Q34553859-DFF8A753-329B-4B26-9ECC-1009D300E19DQ34555445-6AD7AD13-777F-47C0-8A37-7C6F710E42ECQ34585592-0C6322CB-F901-47D2-96A9-47D71E9B0B01Q34669490-92197B91-FC87-43D8-93C7-6EF687560327Q34671668-9C8CCE78-8A5B-46EC-8AA8-DAF93FF43334Q34794421-9EA8FD46-672F-4DE4-86B4-5914CB5599C5Q35148573-A7B0DA18-19F9-4B1C-9528-26F5823EF32FQ35151929-59328370-581B-4CDC-845F-41E27D8AF6E7Q35169652-53915CA3-DAF2-47C9-968A-79BA59428438Q35264312-CF119753-A67F-4ABE-9EE0-105A6AA96CF6Q35325472-C6864623-B775-46D0-A292-647D3D15740AQ35592114-0BC4A9C4-B82F-4F38-9C34-8BF4D1067BE2Q35658393-ACD8DD07-2F3C-40EA-84B5-89F925A75294Q35691485-AAFAA192-2DE0-48CD-ACA3-E84995CDEC54Q35749170-3F27A060-ABFE-4474-A696-B5195643D460
P2860
A targeted proteomics-based pipeline for verification of biomarkers in plasma
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
A targeted proteomics-based pipeline for verification of biomarkers in plasma
@ast
A targeted proteomics-based pipeline for verification of biomarkers in plasma
@en
type
label
A targeted proteomics-based pipeline for verification of biomarkers in plasma
@ast
A targeted proteomics-based pipeline for verification of biomarkers in plasma
@en
prefLabel
A targeted proteomics-based pipeline for verification of biomarkers in plasma
@ast
A targeted proteomics-based pipeline for verification of biomarkers in plasma
@en
P2093
P2860
P356
P1433
P1476
A targeted proteomics-based pipeline for verification of biomarkers in plasma
@en
P2093
Alexei Krasnoselsky
Amanda G Paulovich
Chenwei Lin
Christopher J Kemp
Izabela Sokal
Jacob Kennedy
Jason M Hogan
Jeffrey R Whiteaker
Karen S Kelly-Spratt
P2860
P2888
P304
P356
10.1038/NBT.1900
P577
2011-06-19T00:00:00Z